Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
For more information, please visit www.Trevena.com About TRV045 TRV045 is a novel, highly selective sphingosine-1-phosphate subtype 1 (S1P 1) receptor modulator being developed as a potential ...
Link to Cynthia Erivo Movies and TV Series Ranked by Tomatometer What to Watch: In Theaters and On Streaming. Link to What to Watch: In Theaters and On Streaming. 6 TV and Streaming Shows You ...